Cohance Lifesciences paid a ₹8.30 Cr RBI compounding fee for a past forex violation.

Cohance Lifesciences LimitedCOHANCE · Filed with the exchange

Operationally, the company made strides in FY26, reducing energy intensity by 16.9% and Scope 1&2 GHG by 18.9%. Zero Liquid Discharge is implemented at multiple units.

Exports contribute 84% of turnover.

Read the original filing(PDF)

No comments yet. Be the first.

More from Cohance Lifesciences Limited

All announcements

Updates05-09-2026
General Updates
Updates03-09-2026
Press Release
Important03-09-2026
Committee Meeting Updates
Investor Meet27-08-2026
Analysts/Institutional Investor Meet/Con. Call Updates
Others27-08-2026
Copy of Newspaper Publication
Updates26-08-2026
General Updates

Free

Track this company, and every filing it makes

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

Create a free account

No card needed. Takes about a minute.